Skip to main content
. 2017 Dec 5;7:16913. doi: 10.1038/s41598-017-17190-8

Table 2.

Developmental times of different stages for F1 individuals of S. furcifera when parents (F0) were treated with LC10 and LC30 of buprofezin.

Stages Control LC10 LC30
Mean ± SE Mean ± SE Mean ± SE
1st Instar 2.397 ± 0.0048b 2.900 ± 0.025a 2.214 ± 0.0036c
2nd Instar 2.029 ± 0.016b 2.160 ± 0.030a 2.041 ± 0.018b
3rd Instar 2.049 ± 0.021a 2.022 ± 0.012a 2.025 ± 0.014a
4th Instar 2.494 ± 0.051a 2.178 ± 0.037b 2.135 ± 0.031b
5th Instar 3.063 ± 0.029b 3.379 ± 0.048a 2.648 ± 0.073c
Pre-adult 16.957 ± 0.072c 18.586 ± 0.091a 18.028 ± 0.127b
Adult longevity 13.660 ± 0.504a 13.447 ± 0.409a 9.631 ± 0.399b
Longevity 28.695 ± 0.720a 29.180 ± 0.630a 24.231 ± 0.630b
T. longevity (M) 30.425 ± 0.716a 31.281 ± 0.543a 27.231 ± 0.618b
T. longevity (F) 30.810 ± 0.729b 32.839 ± 0.607a 28.077 ± 0.447c
Fecundity 147.212 ± 12.646a 165.51 ± 26.78a 93.435 ± 9.145b
APOP 1.066 ± 0.037b 2.075 ± 0.103a 2.226 ± 0.120a
TPOP 18.044 ± 0.094c 21.112 ± 0.158a 20.318 ± 0.180b

T. longevity: total longevity, T. longevity (M): total longevity of male, T. longevity (F): total longevity of female, APOP: adult pre-oviposition period, TPOP: total pre-oviposition period, Standard error of the mean (SEM) was calculated using 100,000 bootstraps resampling. A paired bootstrap test was used to detect differences between treatments and control and means followed by different letters within a row show significant difference between the control and different treatments group (at the P < 0.05 level).

HHS Vulnerability Disclosure